Polymorphic low-grade neuroepithelial tumors of the young: disease characteristics and treatment decisions from the epilepsy surgery perspective. He G at all. Front Neurol. 2024 Nov 20;15:1454056.
Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Scoping Review of Case Reports and Case Series. Singh D at all. Asian J Neurosurg. 2024 May 27;19(2):126-136.
Clinical significance of molecular subgroups of polymorphous low-grade neuroepithelial tumor of the young (PLNTY): A small single institutional case series and integrated analysis. Vuong HG at all. Pathol Res Pract. 2023 Dec;252:154922.
Radiological and surgical aspects of polymorphous low-grade neuroepithelial tumor of the young (PLNTY). Armocida D at all. Acta Neurol Belg. 2023 Apr;123(2):327-340.
Neuroradiological features of the polymorphous low-grade neuroepithelial tumor of the young: five new cases with a systematic review of the literature. Kurokawa at all. Neuroradiology. 2022 Jun; 64(6):1255-1264.
Polymorphous low-grade neuroepithelial tumor of the young: Rare tumor and review of the literature. Palejwala AH at all. Rare Tumors. 2022 Mar 28;14:20363613221083360.
Clinical, Radiological, Pathological Features and Seizure Outcome With Surgical Management of Polymorphous Low-Grade Neuroepithelial Tumor of the Young Associated With Epilepsy. Fei X at all. Front Oncol. 2022 Mar 18;12:863373.
Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation. Ida CM at all. J Neuropathol Exp Neurol. Vol. 80, No. 9, September 2021, pp. 821–829
Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Huse JT at all. Acta Neuropathol. 2017 Mar;133(3):417-429.